MERS Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
< b > Condition < /b > :   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) < br/ > < b > Interventions < /b > :   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo < br/ > < b > Sponsor < /b > :   King Abdullah International Medical Research Center < br/ > < b > Not yet recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition:   Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Interventions:   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: PlaceboSponsor:   King Abdullah International Medical Research CenterNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition:   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Interventions:   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo Sponsor:   King Abdullah International Medical Research Center Not yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials